Symposia
Thursday, October 15, 2009
7:30am — 9:30am
Symposium: Update on Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)
Synopsis
Bisphosphonate related osteonecrosis of the jaws is a relatively new entity. Diagnostic and management criteria have been changing as new knowledge evinces itself. This symposium will focus on the latest information that will guide the practitioner in managing these patients
Learning Objectives
At the conclusion of this symposium, participants will be able to:
- Discuss the pathophysiology of BRONJ;
- Discuss the differences in risk between IV and oral agents;
- Describe a treatment plan for management of BRONJ; and
- Discuss research needs.
Moderator
Henry J. Lapointe, DDS, PhD
Chair and Associate Professor, Division of OMS, Schulich School of Medicine and Dentistry, The University of Western Ontario
London, Ontario, Canada
7:30am — 7:55am
Diagnosis of BRONJ
Salvatore L. Ruggiero, DMD, MD
New York Center for Orthognathic and Maxillofacial Surgery, Associate Professor, Stony Brook School of Dental Medicine
Lake Success, NYHandouts Not
Currently Available7:55am — 8:20am
Risks Associated with Oral Bisphosphonates
Joan C. Lo, MD
Physician Scientist at the Division of Research (DOR), Kaiser Permanente and Associate Clinical Professor, Division of Endocrinology, Department of Medicine at the University of California
Oakland, CAHandouts Not
Currently Available8:20am — 8:45am
Risks Associated with IV Bisphosphonates
Thomas B. Dodson, DMD, MPH
Associate Professor, Harvard School of Dental Medicine and Visiting Oral and Maxillofacial Surgeon, Massachusetts General Hospital
Boston, MAHandouts Not
Currently Available8:45am — 9:10am
Treatment of BRONJ
Felice S. O'Ryan, DDS
Director, Division of Oral and Maxillofacial Surgery, Kaiser Permanente Medical Center
Oakland, CA9:10am — 9:30am
Panel Discussion / Audience Q & A
Handouts Not
Currently Available